Documenti analoghi

• A novel ryanodine receptor 2 inhibitor, M201‐A, enhances natriuresis, renal function and lusi‐inotropic actions: Preclinical and phase I study
  di: Noboru Kaneko, et al.
  Pubblicazione: (2024)
• Topical application of a P2X2/P2X3 purine receptor inhibitor suppresses the bitter taste of medicines and other taste qualities
  di: Linda J. Flammer, et al.
  Pubblicazione: (2024)
• Synthesis and evaluation of a novel inhibitor for the α5‐GABA A receptor in the treatment of peripheral neuralgia: Evidence from MD simulation and in vivo studies
  di: Yanming Chen, et al.
  Pubblicazione: (2025)
• The sodium–glucose co‐transporter 2 inhibitor, empagliflozin, attenuates pulmonary vascular remodelling by inhibiting the phosphorylation of PDGF receptor‐β
  di: Ting‐ting Lyu, et al.
  Pubblicazione: (2025)
• Expression of fibroblast growth factor receptor 1 correlates inversely with the efficacy of single‐agent fibroblast growth factor receptor‐specific inhibitors in pancreatic cancer
  di: Qingxiang Lin, et al.
  Pubblicazione: (2024)